688488 Jiangsu Aidea Pharmaceutical
- 9.69
- +0.30+3.19%
Jiangsu Aidea Pharmaceutical News
Eddy Pharmaceutical\'s announcement on the completion of the plan for directors and senior management to reduce shareholding through centralized bidding and share holdings reduction results
Eddy Pharmaceuticals: Eddy Pharmaceuticals Announcement on Pledging Shares in Holding Subsidiaries
Eddy Pharmaceutical\'s announcement on the plan for the company\'s directors and senior management to reduce their shareholding through centralized bidding
Jiangsu Aidea Pharmaceutical's announcement regarding the issuance of A shares to specific objects does not have any investors who directly or indirectly participate in subscriptions through related parties providing financial assistance or compensation.
Jiangsu Aidea Pharmaceutical's announcement on the dilution of immediate return of A-shares issued to specific parties, measures taken to fill the gap, and commitments made by relevant parties.
Announcement of Jiangsu Aidea Pharmaceutical requesting the approval of shareholders' meeting to subscribe to the objects and exempt the persons acting in concert from increasing the company's shares by means of a tender offer.
Jiangsu Aidea Pharmaceutical's plan to issue A-shares of stocks to specific entities in 2024.
Jiangsu Aidea Pharmaceutical's analysis report on the A-share stock issuance plan for specific recipients in 2024.
Jiangsu Aidea Pharmaceutical's shareholder dividend return plan for the next three years (2024-2026)
Jiangsu Aidea Pharmaceutical's feasibility analysis report on the use of funds raised through the issuance of A shares to specific objects in 2024.
Announcement about the disclosure of the A-share stock issuance plan by Jiangsu Aidea Pharmaceutical to specific parties
Announcement on the Progress of Shareholding by Actual Controller and President of Jiangsu Aidea Pharmaceutical
Announcement Regarding the Shareholding Plan of the Actual Controller and President of Jiangsu Aidea Pharmaceutical
Eddy Pharmaceutical's announcement on the completion of the actual controller's plan to increase shareholding and the results of the increase in holdings
Eddy Pharmaceuticals's indicative announcement on planning major asset restructuring and signing the “Intent to Acquire Share Agreement”
Eddy Pharmaceutical\'s announcement on the progress of the actual controller\'s increase in shareholding
Eddy Pharmaceutical\'s announcement on the actual controller\'s plan to increase its shareholding
EDI Pharmaceutical\'s announcement on granting reserve of some restricted shares to incentive recipients of the 2023 Restricted Stock Incentive Plan
Jiangsu Century Tongren Law Firm\'s legal opinion on the grant of some reservations for the 2023 Restricted Stock Incentive Plan of Jiangsu Eddy Pharmaceutical Co., Ltd.
List of incentive recipients reserved for Eddy Pharmaceutical\'s 2023 Restricted Stock Incentive Plan (as of grant date)
Analysis
Price Target
No Data
No Data